XML 74 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACQUISITIONS AND OTHER ARRANGEMENTS - Transderm Scop Narrative (Details)
12 Months Ended
Mar. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Asset Acquisition [Line Items]        
Cash   $ 743,000,000 $ 709,000,000 $ 696,000,000
Transderm Scop        
Asset Acquisition [Line Items]        
Cash $ 60,000,000      
Contingent consideration liability 30,000,000      
Developed Product Rights | Transderm Scop        
Asset Acquisition [Line Items]        
Reacquired license rights fair value total $ 64,000,000      
Weighted-average useful life 9 years      
Developed Product Rights | Measurement Input Discount Rate | Transderm Scop        
Asset Acquisition [Line Items]        
Discount rate used to measure intangible assets 0.225      
Customer relationships | Transderm Scop        
Asset Acquisition [Line Items]        
Reacquired license rights fair value total $ 3,000,000      
Weighted-average useful life 7 years      
Customer relationships | Measurement Input Discount Rate | Transderm Scop        
Asset Acquisition [Line Items]        
Discount rate used to measure intangible assets 0.155